M.F. Eisenga

E-mail:
m.f.eisenga umcg.nl

Research

Publications
  1. Interplay of erythropoietin, fibroblast growth factor 23, and erythroferrone in patients with hereditary hemolytic anemia

    van Vuren, A. J., Eisenga, M. F., van Straaten, S., Glenthøj, A., Gaillard, C. A. J. M., Bakker, S. J. L., de Borst, M. H., van Wijk, R. & van Beers, E. J., 28-Apr-2020, In : Blood. 4, 8, p. 1678-1682 5 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study

    De Jong, M. A., Eisenga, M. F., van Ballegooijen, A. J., Beulens, J. W. J., Vervloet, M. G., Navis, G., Gansevoort, R. T., Bakker, S. J. L. & De Borst, M. H., 3-Mar-2020, In : Nephrology, Dialysis, Transplantation. 8 p., gfz266.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Health-Related Quality of Life in Solid Organ Transplant Recipients With vs Without Keratinocyte Carcinoma

    Frie, M., Annema, C., Knijff, E. S. X., Bakker, S. J. L., Ranchor, A. V., Eisenga, M. F. & Rácz, E., Apr-2020, In : Jama dermatology. 156, 4, p. E1-E3 3 p.

    Research output: Contribution to journalLetterAcademicpeer-review

  4. Urinary Properdin and sC5b-9 Are Independently Associated With Increased Risk for Graft Failure in Renal Transplant Recipients

    Lammerts, R. G. M., Eisenga, M. F., Alyami, M., Daha, M. R., Seelen, M. A., Pol, R. A., van den Born, J., Sanders, J-S., Bakker, S. J. L. & Berger, S. P., 24-Oct-2019, In : Frontiers in Immunology. 10, 10 p., 2511.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (55) »

ID: 492834